ELDERPHARM

Indarts Exports Private Limited has informed the Exchange that they have acquired 2,00,000 shares aggregating to 1.14% of the total paid up capital of Elder Pharmaceuticals Limited on September 26, 2005. The mode of acquisition is Open Market and the shareholding of Indarts Exports Private Limited after the said acquisition is 15,96,350 shares aggregating to 9.13% of the total paid up capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Private Limited has acquired 2,00,000 shares aggregating to 1.14% of the share capital of Elder Pharmaceuticals Limited on September 26, 2005. The mode of acquisition is Open Market and the shareholding of Indarts Exports Private Limited after the said acquisition is 15,96,350 shares aggregating to 9.14% of the share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that the AGM of the shareholders of the Company was held on September 27, 2005 and amongst others the following resolutions were passed: (1) for confirmation of dividend @25% for the year ended March 31, 2005; (2) for re-appointment of Mr. M.V. Thomas as Director (Finance) for a period of five years w.e.f. June 30, 2005; (3) for alteration to the Articles of Association of the Company.

Clarification of News : The press had reports that Elder Pharmaceuticals Limited is setting up two formulations plants - one in Uttranchal and one in Himachal Pradesh. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "It is true that the Company plans to set up two formulation plants in Uttranchal and Himachal Pradesh and one of them is in the adva

Elder Pharmaceuticals Limited has informed the Exchange that the Company has proposed the launch of a molecule "Diacerin" in India under the trade mark "Artrodar". The Company had entered into an in-licensing alliance with TRB Chemedica of Switzerland for this product for Arthritis.

Elder Pharmaceuticals Limited has informed the Exchange that it was decided by the Board to keep the transfer books closed from September 19, 2005 to September 27, 2005 (both days inclusive). Further, it has also been decided to propose re-appointment of Mr. M.V. Thomas as the Director (Finance) of the Company.

Elder Pharmaceuticals Limited has informed the Exchange that the BODs of the Company in its meeting held on August 17, 2005, have taken the following decisions: 1) To hold the AGM of the Company on September 27, 2005. 2) To recommend for consideration of shareholders' declaration of dividend @ 25%. The Company has further informed that the Board has also approved the long term contract for manufacture and supply of dietary fibre supplement in collaboration with Ceejay Healthcare.

Indarts Exports Private Limited had informed the Exchange that they have acquired 250,000 shares aggregating to 1.43% of the total paid up capital of Elder Pharmaceuticals Limited on July 01, 2005 and 250,000 shares aggregating to 1.43% of the total paid up capital of Elder Pharmaceuticals Limited on July 04, 2005. The mode of acquisition is through Open Market and the shareholding of Indarts Exports Private Limited after the said acquisition is 12,96,100 shares aggregating to 7.41% of the total paid up capital of the Company. Indarts Exports Private Limited has now informed the Exchange that

Indarts Exports Private Limited has informed the Exchange that they have acquired 100200 shares aggregating to 0.57% of the total paid up capital of Elder Pharmaceuticals Limited. The details of the acquisition are as follows: (i) 100000 shares on May 23, 2005 through Open Market; and (ii) 200 shares on June 23, 2005 through Private Arrangement. The shareholding of Indarts Exports Private Limited after the said acquisition is 896300 shares aggregating to 5.13% of the total paid up capital of Elder Pharmaceuticals Limited.

Indarts Exports Private Limited has informed the Exchange that they have acquired 50 shares of Elder Pharmaceuticals Limited on July 08, 2005. The mode of acquisition is through open market and the shareholding of Indarts Exports Private Limited after the said acquisition is 1396350 shares aggregating to 7.99% of the total paid up capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited had informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 250,000 shares on July 01, 2005 and 250,000 shares on July 04, 2005, of the Company. The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 12,96,100 shares aggregating to 7.41% of the share capital of Elder Pharmaceuticals Limited. The Company has now amended that the post holding of Indarts Exports Pvt. Ltd. after the said acquisition is 13,96,350 shares aggregating to 7.99% of the share capital of Elder Pharmaceuticals L

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired shares of the Company as follows: (i) 100,000 shares (0.57%) on May 23, 2005 through the Open Market; (ii) 200 shares on June 23, 2005 through Private arrangement; (iii) 50 shares on July 08, 2005 through Private arrangement. The shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 8,96,350 shares aggregating to 5.13% of the share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited had informed the Exchange that Indarts Exports Pvt. Ltd has acquired 500,000 shares aggregating to 2.86% of the total share capital of the Company on July 05, 2005 and the shareholding after the said acquisition is 12,96,100 shares aggregating to 7.41% of the total share capital of Elder Pharmaceuticals Limited. The Company has now amended that the post holding of Indarts Exports Pvt. Ltd. after the said acquisition is 13,96,350 shares aggregating to 7.99% of the share capital of Elder Pharmaceuticals Limited and not 12,96,100 shares as mentioned earlier.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd has acquired 100,250 shares aggregating to 0.57% of the total share capital of Elder Pharmaceuticals Limited on July 08, 2005. The mode of acquisition is through Market Purchase and the shareholding of Indarts Exports Pvt. Ltd after the said acquisition is 8,96,350 shares aggregating to 5.13% of the total share capital of the company.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd. has acquired 250,000 shares on July 01, 2005 and 250,000 shares on July 04, 2005, of the Company. The mode of acquisition is through Open Market and the shareholding of Indarts Exports Pvt. Ltd. after the said acquisition is 12,96,100 shares aggregating to 7.41% of the share capital of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that Indarts Exports Pvt. Ltd has acquired 500,000 shares aggregating to 2.86% of the total share capital of the Company on July 05, 2005. The mode of acquisition is through Market Purchase and the shareholding of Indarts Exports Pvt. Ltd after the said acquisition is 12,96,100 shares aggregating to 7.41% of the total share capital of Elder Pharmaceuticals Limited.

Indarts Exports Private Limited has informed the Exchange that they have acquired 250000 shares aggregating to 1.43% of the total paid up capital of the Elder Pharmaceuticals Limited on July 01, 2005 and 250000 shares aggregating to 1.43% of the total paid up capital of the Elder Pharmaceuticals Limited on July 04, 2005 . The mode of acquisition is through Open Market and the shareholding of Indarts Exports Private Limited after the said acquisition is 1296100 shares aggregating to 7.41% of the total paid up capital of the Company.

Clarification of News : The media had reports that Elder Pharmaceuticals Limited has won outsourcing order from Iceland's Actavis. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "These are only rumours and the Company has not finalized anything with the said party."

Elder Pharmaceuticals Limited has informed the Exchange regarding the change in shareholding of CBC Bahrain and Citicorp International Finance Corporation(PAC).The details of the same are as follows: CBC Bahrain has acquired 1,00,000 equity shares aggregating to 0.57% of the share capital of Elder Pharmaceuticals Limited on May 24, 2005.The mode of acquisition is through Secondary Market Purchases and the shareholding of Citicorp International Finance Corporation after the said acquisition is 12,80,000* shares and that of CBC Bahrain is 5,00,000 shares of Elder Pharmaceuticals Limited. *Citic

Citibank N.A. has informed the exchange regarding the change in shareholding of Citicorp International Finance Corporation(CIFC) with PAC as CBC Bahrain.The details of the same are as follows: CBC Bahrain has acquired 1,65,000 shares aggregating to 0.94% of the share capital of Elder Pharmaceuticals Limited on May 23, 2005.The mode of acquisition through Secondary Market Purchases and the shareholding of Citicorp International Finance Corporation after the said acquisition is 12,80,000 shares aggregating to 7.33% and that of CBC Bahrain is 4,00,000 shares aggregating to 2.29% of the share ca

Citibank N.A. has informed the exchange regarding the change in shareholding of CBC Bahrain and Citicorp International Finance Corporation(PAC).The details of the same are as follows: CBC Bahrain has acquired 1,00,000 equity shares aggregating to 0.57% of the total paid up capital of Elder Pharmaceuticals Limited on May 24, 2005.The mode of acquisition is through Secondary Market Purchases and the shareholding of Citicorp International Finance Corporation after the said acquisition is 12,80,000* shares and that of CBC Bahrain is 5,00,000 shares of Elder Pharmaceuticals Limited.The aggregate s

Elder Pharmaceuticals Limited has informed the Exchange that pursuant to the Special Resolution passed by the shareholders of the Company on February 28, 2005 the Company has on May 19, 2005 issued and allotted 12,80,000 Equity Shares and 4,50,000 warrants of the Company to Citicorp International Finance Corporation (CIFC) on preferential basis.

Citibank has informed the exchange that Citigroup International Finance Corporation along with PAC CBC Bahrain has acquired 12,80,000 equity shares aggregating to 7.30%* of the total paid up capital of Elder Pharmaceuticals Limited on May 19,2005.The mode of acquisition is preferential allotment and the shareholding of Citigroup International Finance corporation along with PAC CBC Bahrain after the said acquisition is 12,80,000 shares aggregating to 7.30%* of the total paid up capital of the company. *Citigroup International Finance Corporation has also been allotted 4,50,000 warrants which i

Elder Pharmaceuticals Limited has informed the Exchange that Citigroup International Finance Corporation has acquired 12,80,000 shares aggregating to 7.30%* of the share capital of Elder Pharmaceuticals Limited on May 19, 2005. The mode of acquisition is through Preferential Allotment and the shareholding of Citigroup International Finance Corporation after the said acquisition is 12,80,000 shares aggregating to 7.30%* of the share capital of Elder Pharmaceuticals Limited. [*Citigroup International Finance Corporation has also been allotted 4,50,000 warrants which is not part of the shares or

Elder Pharmaceuticals Limited has informed the Exchange that pursuant to the Special Resolution passed by the shareholders of the Company on February 28, 2005, the Company has on 10th May 2005 issued and allotted 2,00,000 Equity Shares and 1,50,000 Warrants to ACRAF S.p.A. of Italy on preferential basis. The Company has further informed that w.e.f. April 29, 2005 the Company has co-opted Mr. Edoardo Richter as an Additional Director on the Board of Directors to hold office up to the date of the ensuing AGM of the Company.

News Verification : The press had reports that Elder Pharmaceuticals Limited is considering merging its group company Elder Projects with itself. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "Although we have long term plans of restructuring, definitive plans thereof have not yet been worked out. As and when the same are worked out and put bef

Elder Pharmaceuticals Limited has informed the Exchange that pursuant to the authority vested in the BoDs by the Special Resolution passed by the shareholders at its EGM held on February 28,2005 and pursuant to the in-principle approval received from NSE, the Board has on March 15,2005 issued and allotted 5,00,000 warrants to the Elder Pharma Employees Welfare Trust, Mumbai. In respect of the other two proposed allottees, namely, Citicorp International Finance Corporation, USA and ACRAF S.p.A., Italy the Company has made applications to Foreign Investment Promotion Board (FIPB), Delhi for its

Elder Pharmaceuticals Limited has informed the Exchange that the Company had the EGM of its shareholders on February 28, 2005 when the special resolutions in respect of the following items were passed unanimously: 1)Amendments to the Articles of Association to include the definition of the term 'Securities' and for an enabling provision for issuance of warrants. 2)Authorisation to the Company to allow investment by FIIs in the shares of the Company up to extent of sectoral cap for the Company. 3)Authority to Board to issue shares/warrants to the following parties up to the number mentioned aga

Elder Pharmaceuticals Limited has informed the Exchange that the Managing Director of the Company pursuant to the authority vested in him by the Board in its meeting held on January 28,2005 has decided to convene the EGM of the shareholders of the company on February 28,2005 to consider the matters decided by the Board in its meeting held on January 28,2005.

Elder Pharmaceuticals Limited has informed the Exchange of the decisions taken by the BODs in their meeting held on January 28,2005.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Elder Pharmaceuticals Limited has informed the Exchange that effective January 2005 the ownership of the brand 'Tobraneg' has passed on to the Company from the MNC, Eli Lilly and Company, USA with regard to India, Nepal and Sri Lanka. The Company is going to launch the molecule Tobramycin, an anti-infective drug, under the brand name 'Tobraneg' in the last week of January 2005.

Clarification of News : The press had reports on January 08, 2005 that MNC Eli Lilly India has struck a deal to sell its anti-infective drug Tobraneg to Elder Pharmaceuticals Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "It is true that we have struck a deal with Eli Lilly and Company of USA for purchase of their brand "TOBRANEG" in In

Elder Pharmaceuticals Limited has submitted to the Exchange the details of acquisition of 5% or more shares by Indarts Exports Pvt. Ltd. in Elder Pharmaceuticals Ltd on November 04,2004. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Elder Pharmaceuticals Limited has informed the Exchange that Semit Pharmaceuticals & Chemicals Pvt. Ltd have acquired 260,000 shares representing 1.63% of the voting rights of the Company. The date of acquisition is October 12, 2004 and mode of acquisition is through Private Arrangement. The shareholding of Semit Pharmaceuticals & Chemicals Pvt. Ltd after the said acquisition is 11,41,750 shares representing 7.14% of the voting rights of Elder Pharmaceuticals Limited.

Elder Pharmaceuticals Limited has informed the Exchange that the AGM of the shareholders of the Company was held on September 28, 2004 and amongst others, the following resolutions were passed: 1) confirmation of dividend @25% for the year ended March 31, 2004; 2) issuing/offering/allotting 15,99,000 equity shares of the Company at a price of Rs.160/- per equity share; 3) issuing equity shares under a scheme titled Elder ESOP-2004.